321
Participants
Start Date
November 30, 2004
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
17-alpha-hydroxyprogesterone caproate injectable
250mg of 17-alpha-hydroxyprogesterone caproate (+ preservatives) injectable weekly starting as early as 19wks gestation until 34.0wks gestation of delivery which ever comes first.
Placebo
Weekly doses of placebo (NS + preservatives) via injection as early as 19weeks until 34.0weeks gestation or delivery which ever comes first.
Erlanger Medical Center, Chattanooga
Mercy Medical Center, Des Moines
Saint Luke's Hospital, Kansas City, Kansas City
Baylor University Medical Center, Dallas
Harris Methodist Fort Worth Hospital, Fort Worth
Swedish Medical Center, Denver
Skyridge Medical Center, Lonetree
Presbyterian/St Luke's Hospital, Denver
Rose Medical Center, Denver
Banner Good Samaritan Hospital, Phoenix
Tucson Medical Center, Tucson
Saddleback Memorial Medical Center, Laguna Hills
University of Southern California-Irvine Medical Center, Orange
Good Samaritan Hospital, San Jose
Evergreen Hospital, Kirkland
Tacoma General Hospital, Tacoma
Long Beach Memorial Medical Center, Long Beach
Swedish Medical Center, Seattle
Lead Sponsor
Obstetrix Medical Group
INDUSTRY